Multi-marker prognostic profile to predict invasive progression in dcis patients
Ended Cooperative Agreement Awarded Last action
- Award ID
- R44CA162744
- Recipient
-
Prelude Corporation UEI M6VHTKWWDSH5
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $1,457,355
Award facts
- Assistance listing
- 93.394 Cancer Detection and Diagnosis Research
- Completion date
- Originally
- Place of performance
- Laguna Hills, CA 92653, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $530,138 | |
| Amendment | $653,297 | |
| Original award | $273,920 |
Quick answers
Who received award R44CA162744?
R44CA162744 was awarded to Prelude Corporation by National Institutes of Health (Department of Health and Human Services) on September 20, 2012.
How much is award R44CA162744 worth?
$1,457,355 has been obligated on R44CA162744.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award